INNATE PHARMA SA (IPH.PA)       3.194  -0.05 (-1.66%)

3.194  -0.05 (-1.66%)

FR0010331421 - Common Stock

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
68.974M
-13.67%
56.155M
-18.59%
12.112M
-78.43%
51.869M
328.24%
EBITDA
-10.523M
-183.87%
57.876M
650.00%
-43.229M
-174.69%
-39.685M
8.20%
N/AN/AN/A
EBIT
-27.052M
-625.69%
1.079M
103.99%
-47.825M
-4,532.34%
-32.556M
31.93%
Operating Margin
-39.22%1.92%-394.86%-62.77%
EPS
N/AN/AN/A-0.58N/AN/AN/A

All data in EUR


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q2 / 22
EPSN/A
RevenueN/A
EBITDAN/A
EBITN/A

All data in EUR


EPS and Revenue Surprises


Recent Earnings VS Estimates (EUR)
Period Reported Estimate Difference Surprise Q2 2019 0.20 0.32 -0.12-38.12%
Recent Revenue VS Estimates (EUR)
Period Reported Estimate Difference Surprise Q4 2020 26.31M 27.379M -1.069M-3.90% Q4 2019 17.386M 22.285M -4.899M-21.98% Q2 2019 51.588M 58.735M -7.147M-12.17% Q4 2018 63.01M 38.929M 24.081M61.86% Q4 2017 17.08M 1.515M 15.565M1,027.39% Q2 2017 15.55M 13.534M 2.016M14.90%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPSN/A N/A 0% 0.43%
RevenueN/A N/A 0% 0.39%